#  @NtRf7UTezCBvY5z 快挙!FDA承認済メドレックスちのメドっちさん 快挙!FDA承認済メドレックスちのメドっちさん posts on X about the most. They currently have [--] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours. ### Engagements: [--] [#](/creator/twitter::1484714106980810752/interactions)  - [--] Week [---] +4,000% ### Mentions: [--] [#](/creator/twitter::1484714106980810752/posts_active)  - [--] Week [--] +100% ### Followers: [--] [#](/creator/twitter::1484714106980810752/followers)  ### CreatorRank: [---------] [#](/creator/twitter::1484714106980810752/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) ### Top Social Posts Top posts by engagements in the last [--] hours "Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology # https://www.businesswire.com/news/home/20260113754206/en/Alto-Neuroscience-Presents-New-Data-at-the-64th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology https://www.businesswire.com/news/home/20260113754206/en/Alto-Neuroscience-Presents-New-Data-at-the-64th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology" [X Link](https://x.com/NtRf7UTezCBvY5z/status/2012421899507392557) 2026-01-17T07:09Z [--] followers, [---] engagements "Alto Neuroscience Announces Completion of Enrollment in Phase [--] Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia # https://www.businesswire.com/news/home/20260213343048/en/Alto-Neuroscience-Announces-Completion-of-Enrollment-in-Phase-2-Proof-of-Concept-Study-of-ALTO-101-in-Cognitive-Impairment-Associated-with-Schizophreniautm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork" [X Link](https://x.com/NtRf7UTezCBvY5z/status/2022308597041127722) 2026-02-13T13:55Z [--] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@NtRf7UTezCBvY5z 快挙!FDA承認済メドレックスちのメドっちさん快挙!FDA承認済メドレックスちのメドっちさん posts on X about the most. They currently have [--] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.
Social category influence stocks
Top posts by engagements in the last [--] hours
"Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology # https://www.businesswire.com/news/home/20260113754206/en/Alto-Neuroscience-Presents-New-Data-at-the-64th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology https://www.businesswire.com/news/home/20260113754206/en/Alto-Neuroscience-Presents-New-Data-at-the-64th-Annual-Meeting-of-the-American-College-of-Neuropsychopharmacology"
X Link 2026-01-17T07:09Z [--] followers, [---] engagements
"Alto Neuroscience Announces Completion of Enrollment in Phase [--] Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia # https://www.businesswire.com/news/home/20260213343048/en/Alto-Neuroscience-Announces-Completion-of-Enrollment-in-Phase-2-Proof-of-Concept-Study-of-ALTO-101-in-Cognitive-Impairment-Associated-with-Schizophreniautm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork"
X Link 2026-02-13T13:55Z [--] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::NtRf7UTezCBvY5z